Ordenar

Buscar

01/03/2026 Clinical and Economic Implications of Immunoglobulin Use Under Restrictive Conditions in Adult Patients With Neurological Diseases and Immunodeficiencies in Spain
Querol, L, Montoro-Ronsano, JB, Soler-Palacín, P, Galduf, J, Martínez-Pérez, O, Díaz-Cuervo, H. Clinical and Economic Implications of Immunoglobulin Use Under Restrictive Conditions in Adult Patients With Neurological Diseases and Immunodeficiencies in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2026; 33(3)DOI:10.1111/ene.70570. PMID:41834317. IF:3.900(Q1/3D).
01/03/2026 Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT
Schmidt-Hieber, M, Ljungman, P, Gilbert, P, Knelange, N, Drozd-Sokolowska, J, Basak, G, Einsele, H, Tridello, G, Abdeljelil, NB, Kulagin, A, Balaguer-Rosello, A, Metafuni, E, Faraci, M, Gozdzik, J, Martino, R, Raiola, AM, Xhaard, A, Kuskonmaz, B, Biffi, A, Czyzewski, K, Gabriel, MA, Martínez-Lopez, J, Zaidman, I, Schlegel, PG, Gruhn, B, Krivan, G, Vicent, MG, Mikulska, M, Peric, Z, Averbuch, D, Styczynski, J, Penack, O, de la Camara, R. Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT. Eclinicalmedicine. 2026; 93DOI:10.1016/j.eclinm.2026.103792. PMID:41783087. IF:10.000(Q1/1D).
01/03/2026 Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospects
Mur, P, Pozuelo, A, Tabernero, J, Albanell, J, Bellosillo, B, Bosch, F, Briones, J, Brunet, J, Colomer, D, Domènech, M, Fontanet, JM, Matias-Guiu, X, Salazar, R, Vivanco-Hidalgo, RM, Mollà, M, Moreno, L, Prat, A, Ribera, JM, Clèries, R, Guarga, A, Espinàs, JA, Borras, JM. Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospects. Clinical & Translational Oncology. 2026; 28(3)DOI:10.1007/s12094-025-04022-9. PMID:40900393. IF:2.500(Q3/6D).
01/03/2026 Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia
Mecklenbrauck, R, Ramiro, AV, Sträng, E, Gabdoulline, R, Elicegui, JM, Sobas, M, Pleyer, L, Turki, A, Voso, MT, Benner, A, Hernández-Sánchez, A, Tettero, JM, Gimenez, LT, Metzeler, KH, Oñate, G, Lehmann, S, Huntly, BJP, Thomas, I, Thol, FR, Heidel, FH, Valk, PJM, Döhner, K, Haferlach, T, Mills, KI, Döhner, H, Castellani, G, Ossenkoppele, GJ, Hernández-Rivas, JM, Bullinger, L, Heuser, M. Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia. LEUKEMIA. 2026; 40(3)DOI:10.1038/s41375-026-02874-w. PMID:41663622. IF:13.400(Q1/1D).